Anson Funds Management’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Anson Funds Management’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-233,330	Closed	-$518K	–	119
2019 Q4	$518K	Buy	+233,330	New	+$20.5K	0.6%	48

Anson Funds Management's CLRBZ Position: Q1 2020 in Review

Anson Funds Management sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q1 2020, closing a stake of 233,330 shares — an estimated $518K sold.

Anson Funds Management first reported a position in CLRBZ in Q4 2019 and held it in 1 quarter. The position peaked at $518K in Q4 2019. 1 fund tracked by Wall St. Rank holds CLRBZ as of Q1 2020.

Anson Funds Management reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q1 2020 after selling out during the quarter.
Anson Funds Management sold 233,330 Cellectar Biosciences, Inc. Series A Warrants shares in Q1 2020, an estimated $518K.
Anson Funds Management first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q4 2019 and held it in 1 quarter.
Anson Funds Management's Cellectar Biosciences, Inc. Series A Warrants position peaked at $518K in Q4 2019.
1 fund tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q1 2020.

Based on Anson Funds Management's 13F filing for Q1 2020, filed 15 May 2020.